Quantinno Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quantinno Capital Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.07M	Buy	71,133 +18,986	+36%	+$1.04M	﹤0.01%	1408
2026 Q1	$2.95M	Buy	52,147 +15,225	+41%	+$888K	﹤0.01%	1395
2025 Q4	$2.19M	Buy	36,922 +16,810	+84%	+$915K	﹤0.01%	1331
2025 Q3	$1.09M	Buy	20,112 +3,936	+24%	+$225K	﹤0.01%	1449
2025 Q2	$889K	Buy	16,176 +3,454	+27%	+$203K	﹤0.01%	1354
2025 Q1	$899K	Buy	12,722 +6,874	+118%	+$462K	0.01%	1186
2024 Q4	$384K	Buy	+5,848	New	+$392K	﹤0.01%	1308

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Quantinno Capital Management's BMRN Position: Q2 2026 in Review

Quantinno Capital Management increased its BioMarin Pharmaceuticals (BMRN) stake by 36% in Q2 2026, buying an estimated $1.04M and bringing the position to 71,133 shares worth $4.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1408.

Quantinno Capital Management first reported a position in BMRN in Q4 2024 and has held it in 7 quarters since. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Quantinno Capital Management held 71,133 shares of BioMarin Pharmaceuticals worth $4.07M as of Q2 2026.
Quantinno Capital Management bought 18,986 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $1.04M.
BioMarin Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1408 holding.
Quantinno Capital Management first reported a position in BioMarin Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.